Delivery Order SPE2DB22D1017-SPE2DB25FG4DS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $38,528.12 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on June 18, 2025, with an ultimate completion date of June 20, 2025. This non-competitive, firm fixed-price delivery order will be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen's broader Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $22,972.76 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen injectors on August 14, 2025, with completion expected by August 15, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $12,741.60 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors on December 2, 2025, with a completion date of December 3, 2025. This non-competitive, firm fixed-price delivery order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $9,133.25 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Dupixent 300 mg/2 ml pen injections. This is a firm fixed price delivery order with an ultimate completion date of July 29, 2025, representing a short-duration pharmaceutical supply contract. The award carries no set-aside designation, indicating it was competitively awarded through open procurement processes. AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $5,987.47 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitive award, issued under firm fixed pricing, represents a child contract to AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- The Defense Logistics Agency awarded a $16,998.05 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injectors on July 14, 2025, with completion scheduled for July 15, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery is scheduled to occur at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $33,110.91 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen auto-injectors on October 21, 2025, with an ultimate completion date of October 22, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order will be fulfilled from...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Dupixent 300 mg/2 ml pen auto-injectors with a firm fixed price ceiling value of $24,740.80 and an ultimate completion date of December 2, 2025. This non-competitive delivery order represents a continuation of AmerisourceBergen's substantial role as a critical pharmaceutical supplier to the federal government. The award is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order valued at $3,418.92 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen auto-injectors on September 12, 2025, with a completion date of September 15, 2025. This competitive, non-set-aside contract represents a firm fixed-price delivery order for pharmaceutical supplies to be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued as a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Dupixent 300 mg/2 ml pen injectors with a ceiling value of $32,444.88 and firm fixed pricing. This is a non-set-aside competitive award with an ultimate completion date of September 2, 2025, with performance to be executed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under a larger Indefinite Delivery Contract...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG4DSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,439.47 to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of Dupixent 300 mg/2 mL pen auto-injectors. This non-competitive delivery order represents a firm fixed-price transaction with an ultimate completion date of June 5, 2025, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that provides comprehensive pharmaceutical support globally to military healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, maintains an extensive portfolio of federal contract awards with the Defense Logistics Agency covering diverse pharmaceutical products and medical supplies. The company's demonstrated capability to compete successfully in open federal procurement and manage large-scale medical supply operations positions it as a key provider for military and veteran healthcare systems. This specific delivery order for Dupixent, a specialty immunology medication, reflects the company's role in supplying brand-name therapeutics and specialized healthcare commodities essential to military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 6/4/25 |